Synthetic Biologics, Inc. (SYN)
Equity Ratio
34.96%
Quarterly · Period ending:
SYN Equity Ratio
Latest reported34.96%period ending
Latest reported34.96%period ending
SYN Quarterly Equity Ratio (82.00% → 34.96%)
Latest values, visible window
High-resolution chart · PNG
SYN equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 34.9628% | |
| 40.2609% | |
| 40.2286% | |
| 21.8511% | |
| 29.6483% | |
| 48.1857% | |
| 53.9347% | |
| 61.4217% | |
| 65.2182% | |
| 70.0246% | |
| 71.8901% | |
| 71.3039% | |
| 72.9622% | |
| 74.5161% | |
| 75.9299% | |
| 73.8916% | |
| 74.9098% | |
| 76.4357% | |
| 92.9553% | |
| 97.6212% | |
| 99.0292% | |
| 100.6881% | |
| 95.4935% | |
| 92.7669% | |
| 90.8265% | |
| 96.6097% | |
| 83.3478% | |
| 83.9408% | |
| 93.5081% | |
| 97.1763% | |
| 97.4221% | |
| 78.7421% | |
| 67.5457% | |
| 71.597% | |
| -7.9414% | |
| -20.5679% | |
| 30.6861% | |
| 14.4986% | |
| 17.0904% | |
| -54.2677% | |
| 14.0469% | |
| 27.5162% | |
| 52.0376% | |
| 60.6746% | |
| -115.4093% | |
| -11.8475% | |
| 49.9164% | |
| 79.2449% | |
| 86.737% | |
| 93.8313% | |
| 93.6827% | |
| 91.6007% | |
| 97.6213% | |
| 98.3225% | |
| 97.0573% | |
| 92.8424% | |
| 94.548% | |
| 94.694% | |
| 94.4222% | |
| 97.2754% | |
| 95.7964% | |
| 83.3446% | |
| 87.0473% | |
| 90.5761% | |
| 84.8434% | |
| 84.6904% | |
| 86.9607% | |
| 91.1516% | |
| 89.9812% | |
| 88.2856% | |
| 91.5953% | |
| 91.7496% | |
| 91.3287% | |
| 87.8473% | |
| 87.6218% | |
| 81.1159% | |
| 84.7306% | |
| 90.1497% | |
| 94.175% | |
| -1,305.7388% | |
| -1,015.8058% | |
| -803.9571% | |
| -572.4399% | |
| -472.1852% | |
| -441.8797% | |
| -169.7446% | |
| -80.6562% | |
| -53.1657% | |
| -7.5903% | |
| -20.0346% | |
| -5.1064% | |
| 34.7781% | |
| 13.2921% | |
| -200% | |
| -94.4444% | |
| -21.7391% | |
| 24.1379% | |
| 51.6129% | |
| 80% | |
| -1,850% |